Global Anti-Snoring Devices Market Overview, 2023-28

Anti-snoring devices are now widely used as a result of recent advances in sleep disorders as well as an increase in interest in innovative device development.

Featured Companies

  • 1. Koninklijke Philips
  • 2. ResMed
  • 3. LivaNova PLC
  • 4. Fisher & Paykel Healthcare Corporation Limited
  • 5. SomnoMed Inc
  • 6. Medtronic plc
  • 7. Meditas Ltd
  • 8. Airway Management Inc
  • 9. SnoreMeds Inc
  • More...

To address the issue of primary snoring, anti-snoring devices are used. In addition to devices, surgery is used to treat primary snoring. The majority of the surgeries is performed as outpatients and is minimally invasive. Advances in disease treatment include anti-snoring devices and snoring surgery, among other things. Anti-snoring devices are now widely used as a result of recent advances in sleep disorders and snoring research and development, as well as an increase in interest in innovative device development. Furthermore, as the world's population ages, so does the demand for anti-snoring devices. Snoring and related health issues, such as sleep apnea, are more common in the elderly, driving demand for these products. Furthermore, there is a growing emphasis on sleep quality, with many people recognizing the importance of getting a good night's sleep for overall health and well-being. This is increasing demand for anti-snoring devices as a way to improve sleep quality. Furthermore, the prevalence of snoring is increasing globally, fueling demand for anti-snoring devices. This is due to a number of factors, including obesity, unhealthy lifestyle choices, and an ageing population.

According to Bonafide Research's research report, "Global Anti-Snoring Device Market Overview, 2023-28," the global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022. An increase in tobacco and alcohol consumption, as well as increased awareness of the negative consequences of snoring caused by these factors, are driving the market. Throughout the forecast period, technological advancements in the market will drive the global anti-snoring device market. Furthermore, low-cost and minimally invasive devices, combined with associated product benefits, may drive demand. Additionally, the rising prevalence of obesity, diabetes, and other chronic diseases has an effect. Furthermore, an increase in the geriatric population base susceptible to obesity boosts demand for anti-snoring products. The growing patient preference for anti-snoring devices will drive demand for such devices, propelling the anti-snoring device market forward. Furthermore, rising snoring awareness, increased disposable income, and advanced product development will drive demand for anti-snoring devices in the coming years.

Based on product type, the market is segmented into mandibular advancement devices, nasal devices, position control devices, chin straps, EPAP/CPAP, and tongue stabilizing devices. Among them, In the Global market, MADs have the largest market share among the various types of anti-snoring and sleep apnea devices. This is due to their effectiveness, ease of use, and comfort for patients. MADs are typically custom-fitted to each patient's mouth by a dentist or sleep specialist. Furthermore, One advantage of MADs is that they are relatively non-invasive compared to other sleep apnea treatments, such as surgery or continuous positive airway pressure (CPAP) therapy. MADs are also portable and easy to use, making them a convenient option for people who travel frequently. EPAP/CPAP is expected to grow at a higher CAGR during the forecast period. This is due to the increasing prevalence of sleep apnea in the region, as well as the growing awareness among patients and healthcare providers about the benefits of EPAP/CPAP therapy.

The market is divided into hospital, clinic, retail pharmacy, and e-commerce segments based on the distribution channel. Among them, Hospitals have the largest market share among the various types of anti-snoring and sleep apnea devices. Hospitals are the primary channel for the distribution of sleep apnea devices in global, as they are the primary source of diagnosis and treatment for sleep-disordered breathing. Hospitals offer a range of diagnostic tests, including polysomnography, which is used to diagnose sleep apnea and other sleep disorders. After diagnosis, hospitals often prescribe and dispense anti-snoring and sleep apnea devices to patients. E-commerce is expected to grow at a higher CAGR during the forecast period. One of the main drivers of the growth in e-commerce for anti-snoring and sleep apnea devices is the increasing popularity of online shopping among consumers. Many consumers prefer the convenience and accessibility of online shopping, particularly for products that are often viewed as personal or sensitive, such as anti-snoring and sleep apnea devices.

Among all the regions, North America is expected to dominate the global anti-snoring devices market in the year 2022 and is expected to do the same during the forecast period from 2023-2028. Some of the recent product launches include the new anti-snoring device called the Ebb Sleep System, which uses cooling technology to reduce nasal congestion and inflammation, was effective in reducing snoring and improving sleep quality in people with mild to moderate obstructive sleep apnea. Furthermore, the FDA cleared a new anti-snoring device called the Smart Nora, which uses a unique pillow insert and a bedside monitoring device to detect snoring and adjust the pillow's position to help reduce snoring. Moreover, an anti-snoring device called the Night Balance, which uses positional therapy to encourage side sleeping, was effective in reducing snoring and improving sleep quality in people with positional obstructive sleep apnea. In addition, an anti-snoring device called the Winx Sleep System, which uses negative pressure to gently suction the soft palate and tongue forward, was effective in reducing snoring and improving sleep quality in people with snoring and mild to moderate obstructive sleep apnea.
Snoring and sleep apnea are common sleep disorders that affect millions of people worldwide. As the global population continues to grow and age, the prevalence of these disorders is expected to increase, driving demand for anti-snoring devices. Furthermore, obesity is a major risk factor for snoring and sleep apnea, and with the global rise in obesity rates, the prevalence of these sleep disorders is expected to increase, driving demand for anti-snoring devices. Moreover, the emergence of smart anti-snoring devices, the market entry of sleep-based start-up companies, the emergence of the latest generation of Herbst-style oral appliances, and new launches and approvals of anti-snoring devices are some significant trends in the anti-snoring devices market.

Restraints:
The global anti-snoring device market is subject to various regulatory requirements, such as safety and efficacy standards. Compliance with these regulations can be challenging and costly, which can limit the entry of new players and limit the overall market growth. Furthermore, some anti-snoring devices may cause discomfort or side effects, such as dry mouth, sore throat, or nasal congestion. This can lead to low compliance and limit the overall market growth. Moreover, here are alternative treatments for snoring and sleep apnea, such as surgery or positional therapy. Some people may choose these alternatives instead of using anti-snoring devices, which can limit the overall market growth.

Developments:
• In May 2022, Illusion Aligners launched a new innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night.
• In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. The U.S. FDA approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA''.

Companies Mentioned in this Report:
Koninklijke Philips N.V., LivaNova PLC, Fisher & Paykel Healthcare Corporation Limited., SomnoMed Inc, Medtronic plc, Meditas Ltd., ResMed Inc., Airway Management Inc., SnoreMeds Inc., PureSleep Company Inc.

Considered in this report
• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report
• Global Anti-Snoring market with its value and forecast along with its segments
• Region-wise Guitar market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

By Product Type:
• Mandibular Advancement Device
• Nasal Device
• Position Control Device
• Chin Straps
• EPAP/CPAP
• Tongue Stabilizing

By Distribution Chanel:
• Hospitals
• Clinics
• Retail Pharmacies
• E-commerce
• Others

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, government-generated reports, and databases. After gathering the data from secondary sources, primary research was conducted by making telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started doing primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations and organizations related to the Anti Snoring Device industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.



What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Companies Mentioned

  • Koninklijke Philips
  • ResMed
  • LivaNova PLC
  • Fisher & Paykel Healthcare Corporation Limited
  • SomnoMed Inc
  • Medtronic plc
  • Meditas Ltd
  • Airway Management Inc
  • SnoreMeds Inc
  • PureSleep Company Inc

Table of Contents

  • Table of Content
  • 1. Executive Summary
  • 2. Market Dynamics
  • 2.1. Market Drivers
  • 2.2. Challenges
  • 2.3. Opportunity
  • 2.4. Restraints
  • 2.5. Market Trends
  • 2.6. Covid-19 Effect
  • 2.7. Supply chain Analysis
  • 2.8. Policy & Regulatory Framework
  • 2.9. Industry Experts Views
  • 3. Research Methodology
  • 3.1. Secondary Research
  • 3.2. Primary Data Collection
  • 3.3. Market Formation & Validation
  • 3.4. Report Writing, Quality Check & Delivery
  • 4. Market Structure
  • 4.1. Market Considerate
  • 4.2. Assumptions
  • 4.3. Limitations
  • 4.4. Abbreviations
  • 4.5. Sources
  • 4.6. Definitions
  • 5. Economic /Demographic Snapshot
  • 6. Competitive Landscape
  • 6.1. Competitive Dashboard
  • 6.2. Business Strategies Adopted by Key Players
  • 6.3. Key Players Market Share Insights and Analysis, 2022
  • 6.4. Key Players Market Positioning Matrix
  • 6.5. Consolidated SWOT Analysis of Key Players
  • 6.6. Porter's Five Forces
  • 7. Global Anti-Snoring Market Outlook
  • 7.1. Market Size By Value
  • 7.2. Market Size and Forecast, By Geography
  • 7.3. Market Size and Forecast, By Product Type
  • 7.4. Market Size and Forecast, By Distribution Channel
  • 8. North America Anti-Snoring Market Outlook
  • 8.1. Market Size By Value
  • 8.2. Market Share By Country
  • 8.3. Market Size and Forecast By Product Type
  • 8.4. Market Size and Forecast By Distribution Channel
  • 9. Europe Anti-Snoring Market Outlook
  • 9.1. Market Size By Value
  • 9.2. Market Share By Country
  • 9.3. Market Size and Forecast By Product Type
  • 9.4. Market Size and Forecast By Distribution Channel
  • 10. Asia-Pacific Anti-Snoring Market Outlook
  • 10.1. Market Size By Value
  • 10.2. Market Share By Country
  • 10.3. Market Size and Forecast By Product Type
  • 10.4. Market Size and Forecast By Distribution Channel
  • 11. South America Anti-Snoring Market Outlook
  • 11.1. Market Size By Value
  • 11.2. Market Share By Country
  • 11.3. Market Size and Forecast By Product Type
  • 11.4. Market Size and Forecast By Distribution Channel
  • 12. Middle East & Africa Anti-Snoring Market Outlook
  • 12.1. Market Size By Value
  • 12.2. Market Share By Country
  • 12.3. Market Size and Forecast By Product Type
  • 12.4. Market Size and Forecast By Distribution Channel
  • 13. Company Profile
  • 13.1. Koninklijke Philips N.V.
  • 13.1.1. Company Snapshot
  • 13.1.2. Company Overview
  • 13.1.3. Financial Highlights
  • 13.1.4. Geographic Insights
  • 13.1.5. Business Segment & Performance
  • 13.1.6. Product Portfolio
  • 13.1.7. Key Executives
  • 13.1.8. Strategic Moves & Developments
  • 13.2. LivaNova PLC
  • 13.3. Fisher & Payker Healthcare
  • 13.4. SomnoMed Inc
  • 13.5. Medtronic plc
  • 13.6. Meditas Ltd.
  • 13.7. Resmed
  • 13.8. Airway Management Inc.
  • 13.9. SnoreMeds
  • 13.10. puresleep
  • 14. Strategic Recommendations
  • 15. Annexure
  • 15.1. FAQ`s
  • 15.2. Notes
  • 15.3. Related Reports
  • 16. Disclaimer

List of Tables

Table 1: Global Anti-Snoring Market Snapshot, By Segmentation (2022 & 2028) (in USD Billion)
Table 2: Influencing Factors for Global Anti-Snoring Market, 2022
Table 3: Top 10 Counties Economic Snapshot 2020
Table 4: Economic Snapshot of Other Prominent Countries 2020
Table 5: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 6: Global Anti-Snoring Market Size and Forecast, By Geography (2017 to 2028F) (In USD Billion)
Table 7: Global Anti-Snoring Market Size and Forecast, By Product Type (2017 to 2028F) (In USD Billion)
Table 8: Global Anti-Snoring Market Size and Forecast, By Distribution Channel (2017 to 2028F) (In USD Billion)
Table 9: North America Anti-Snoring Market Size and Forecast By Product Type (2017 to 2028F) (In USD Billion)
Table 10: North America Anti-Snoring Market Size and Forecast By Distribution Channel (2017 to 2028F) (In USD Billion)
Table 11: Europe Anti-Snoring Market Size and Forecast By Product Type (2017 to 2028F) (In USD Billion)
Table 12: Europe Anti-Snoring Market Size and Forecast By Distribution Channel (2017 to 2028F) (In USD Billion)
Table 13: Asia-Pacific Anti-Snoring Market Size and Forecast By Product Type (2017 to 2028F) (In USD Billion)
Table 14: Asia-Pacific Anti-Snoring Market Size and Forecast By Distribution Channel (2017 to 2028F) (In USD Billion)
Table 15: South America Anti-Snoring Market Size and Forecast By Product Type (2017 to 2028F) (In USD Billion)
Table 16: South America Anti-Snoring Market Size and Forecast By Distribution Channel (2017 to 2028F) (In USD Billion)
Table 17: Middle East & Africa Anti-Snoring Market Size and Forecast By Product Type (2017 to 2028F) (In USD Billion)
Table 18: Middle East & Africa Anti-Snoring Market Size and Forecast By Distribution Channel (2017 to 2028F) (In USD Billion)

List of Figures

Figure 1: Global Anti-Snoring Market Size (USD Billion) By Region, 2022 & 2028
Figure 2: Market attractiveness Index, By Region 2028
Figure 3: Market attractiveness Index, By Segment 2028
Figure 4: Competitive Dashboard of top 5 players, 2022
Figure 5: Market Share insights of key players, 2022
Figure 6: Porter's Five Forces of Global Anti-Snoring Market
Figure 7: Global Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 8: Global Anti-Snoring Market Share By Region (2022)
Figure 9: North America Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 10: North America Anti-Snoring Market Share By Country (2022)
Figure 11: Europe Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 12: Europe Anti-Snoring Market Share By Country (2022)
Figure 13: Asia-Pacific Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 14: Asia-Pacific Anti-Snoring Market Share By Country (2022)
Figure 15: South America Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 16: South America Anti-Snoring Market Share By Country (2022)
Figure 17: Middle East & Africa Anti-Snoring Market Size By Value (2017, 2022 & 2028F) (in USD Billion)
Figure 18: Middle East & Africa Anti-Snoring Market Share By Country (2022)

Market Research FAQs

The global anti-snoring device market is expected to reach more than USD 2 Billion by 2028, with a CAGR of 7.92% from USD 1.47 Billion in 2022.

The growth of the global anti-snoring market may be driven by factors such as the increasing prevalence of snoring and sleep apnea, rising awareness and diagnosis of sleep disorders, technological advancements in anti-snoring devices, and increasing demand for non-invasive treatment options.

Koninklijke Philips N.V., LivaNova PLC, Fisher & Paykel Healthcare Corporation Limited., SomnoMed Inc, Medtronic plc, Meditas Ltd., ResMed Inc., Airway Management Inc., SnoreMeds Inc., PureSleep Company Inc.

Some of the challenges facing the global anti-snoring market may include the high cost of some devices, low patient compliance and adherence to treatment, and limited access to healthcare and diagnosis in some regions.

The future outlook for the global anti-snoring market looks promising, with increasing awareness of the health risks associated with snoring and sleep apnea and technological advancements in anti-snoring devices expected to drive growth. However, challenges such as patient compliance and access to healthcare may also need to be addressed to realize the full potential of the market.
Logo

Global Anti-Snoring Devices Market Overview, 2023-28

Contact usWe are friendly and approachable, give us a call.